
Opinion|Videos|March 14, 2025
Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis
Panelists discuss how JAK inhibitors demonstrate significant efficacy in treating atopic dermatitis while examining their safety profiles and optimal positioning within the therapeutic landscape.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
2
KT-621 Produces 98% STAT6 Degradation in AD Patients
3
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
4
Site-Specific MED Variability Guides 308-nm Excimer Laser Dosing
5

















